FDA Inspection 999883 — Piotr L. Rutkowski, M.D., Ph.D.
The FDA completed an inspection of Piotr L. Rutkowski, M.D., Ph.D. on December 8, 2016 in Warsaw. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- December 8, 2016
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Warsaw (Poland)
Additional Details
Clinical Investigator (CI)